PTK2 and carcinoma of esophagus: Moreover, the PAR signaling pathway illustrates that PPAR gamma antagonists inhibited the invasion and cell adhesion of esophageal carcinoma cells, probably due to alteration of the FAK-MAPK pathway, which was unrelated to apoptosis.